L-Carnitine is best known for its function as a shuttling molecule for the import of long-chain fatty acids into the mitochondrial matrix where fatty acids are oxidized for energy generation (Fritz, 1959) . Due to this, L-carnitine is intrinsically linked with fatty acid β-oxidation. However, L-carnitine is generally important for energy metabolism because it also promotes energy production from glucose through regulating the activity of the pyruvate dehydrogenase complex, which is a key enzyme of energy metabolism connecting glycolysis and tricarboxylic acid cycle. Due to these functions of L-carnitine, numerous studies have investigated the potential of Lcarnitine as feed additive to improve performance of different monogastric and ruminant livestock species (reviewed by Eder, 2009; Ringseis, , with, however, discrepant outcomes.
| INTRODUC TI ON
L-Carnitine is best known for its function as a shuttling molecule for the import of long-chain fatty acids into the mitochondrial matrix where fatty acids are oxidized for energy generation (Fritz, 1959) . Due to this, L-carnitine is intrinsically linked with fatty acid β-oxidation. However, L-carnitine is generally important for energy metabolism because it also promotes energy production from glucose through regulating the activity of the pyruvate dehydrogenase complex, which is a key enzyme of energy metabolism connecting glycolysis and tricarboxylic acid cycle. Due to these functions of L-carnitine, numerous studies have investigated the potential of Lcarnitine as feed additive to improve performance of different monogastric and ruminant livestock species (reviewed by Eder, 2009; , with, however, discrepant outcomes.
In order to understand the reasons for these discrepant outcomes, it is important to consider the determinants of L-carnitine status and how L-carnitine status is regulated in the animal's body. While it is a long-known fact that L-carnitine is endogenously biosynthesized in certain tissues, it was only recently recognized that critical determinants of L-carnitine status, such as intestinal L-carnitine absorption, tissue L-carnitine uptake, endogenous L-carnitine synthesis and renal L-carnitine reabsorption, are regulated by specific nutrient sensing nuclear receptors . These receptors in general have the ability to sense variations in environmental nutrient supply and translate this signal into a physiologic response via affecting gene transcription (Efeyan, Comb, & Sabatini, 2015 ; Preidis, Kim, & Moore, 2017) . Through this, the animal's body L-carnitine biosynthesis. Considering the literature, no indications exist that a complete failure of endogenous L-carnitine biosynthesis due to a deficiency of critical genes (TMLD, TMABA-DH, BBD) plays a role in farm animals. In the practical situation, it is more likely that the L-carnitine status of monogastric animals is affected by an impaired L-carnitine biosynthesis resulting from a decreased availability of nutrients required as cofactors (ascorbic acid, pyridoxine, iron) for enzymes involved in endogenous L-carnitine biosynthesis.
| Intestinal L-carnitine absorption
As indicated in the section before, absorption of L-carnitine from dietary sources in the intestine is a further determinant of L-carnitine status in monogastrics. Typical feeding rations for pigs and poultry consist mainly of plant-based products such as corn and soya bean meal. Considering that grains and legume seeds in general have only a low L-carnitine concentration (5.9-6.8 mg/kg DM; Knüttel-Gustavsen & Harmeyer, 2007 ) when compared to animal-based products, ingestion of L-carnitine from such rations in pigs and poultry is relatively low. Data on the intestinal L-carnitine absorption rate are only available for pigs. According to a recent study in young growing pigs, in which the praecaecal absorption rate of a wide range of supplemental dietary L-carnitine levels (0-1,000 mg/ kg diet) was determined by the indicator method, dietary L-carnitine is very efficiently absorbed from the small intestine (>90%; Fischer, Varady, Hirche, Kluge, & Eder, 2009 ). L-carnitine absorption from dietary sources in the small intestine of mammals has long been known to be mediated by a saturable, electrogenic, pH-dependent and sodium-dependent process (Gudjonsson, Li, Shug, & Olsen, 1985; Hamilton, Li, Shug, & Olsen, 1986; Shaw, Li, Hamilton, Shug, & Olsen, 1983 ). This L-carnitine transport process was later found to be accomplished by the OCTN2 (Yokogawa et al., 1999) , which has been identified in the apical surface of small intestinal epithelial cells (Kato et al., 2006) . Based on observations in mice with a genetic defect in the OCTN2 gene (Yokogawa et al., 1999) , OCTN2 contributes the most to L-carnitine absorption in the intestine, while other intestinal transporters capable of transporting L-carnitine, such as OCTN1 and ATB
0+
, play only a minor role. The presence of OCTN2 in the small intestinal mucosa of pigs and the similar in vivo regulation of OCTN2 expression in pigs as in mice suggests that OCTN2 is also an important L-carnitine transport system in the small intestine of pigs (Ringseis, Luci et al., 2008; Ringseis et al., 2009) . This is further supported by the observation that the porcine OCTN2 gene contains a functional cis-acting element which shows 100% sequence identity with that of the mouse OCTN2 gene and is identically regulated (Luo et al., 2014) . Although the evidence is rather indirect, OCTN2 is probably also responsible for intestinal L-carnitine absorption in avian species given that L-carnitine transport in the apical membrane of enterocytes from chicken broilers was found to show the typical characteristics of OCTN2, such as dependence on sodium and pH and inhibition by palmitoyl-L-carnitine (Durán, Peral, Calonge, & Ilundáin, 2002) . However, unlike the porcine OCTN2 gene, the chicken OCTN2 gene shows less sequence homology with the mouse OCTN2 gene with regard to the functional cis-acting element ( Ringseis et al., 2012) , that is central to the physiologic regulation of OCTN2 expression (Wen, Ringseis, & Eder, 2010) .
| L-Carnitine excretion
Finally, L-carnitine status in monogastric farm animals is determined by L-carnitine excretion via different routes including urine, faeces, milk (mammals) and eggs (avian species). Excretion of L-carnitine via the urine is an important mechanism contributing to L-carnitine homoeostasis in the case that plasma L-carnitine concentration exceeds the normal range due to ingestion of high L-carnitine doses.
In fact, studies in humans and cattle show that urinary L-carnitine excretion is dramatically increased when high doses of L-carnitine are administered (Engel et al., 1981; LaCount, Drackley, & Weigel, 1995; Rebouche & Chenard, 1991) . This is explained by the fact that under this condition, the tubular L-carnitine reabsorption mechanism, which is also governed by OCTN2, is saturated and thus excess L-carnitine is rapidly eliminated via the urine (Engel et al., 1981; Rebouche & Chenard, 1991) . Because almost all of the free L-carnitine filtered in the kidney is reabsorbed via OCTN2, renal Lcarnitine reabsorption is also of critical importance for maintaining physiologic plasma L-carnitine levels in the case that L-carnitine is not sufficiently provided with the diet and L-carnitine biosynthesis is impaired. This is best known from patients carrying a mutation in the OCTN2 gene (Scaglia et al., 1998) . Although most of the knowledge about the kinetics of urinary L-carnitine excretion in mammals is derived from studies with humans, rats and cattle (Engel et al., 1981; LaCount et al., 1995; Ohnishi et al., 2008; Rebouche & Chenard, 1991) and studies with regard to this topic in pigs and poultry are lacking, it is likely that urinary L-carnitine excretion and renal L-carnitine reabsorption are also key mechanisms in the regulation of L-carnitine homeostasis. Indeed, OCTN2 has been shown to be expressed in the kidney of pigs (Ringseis et al., 2009) and to be identically regulated by nutrient sensing nuclear receptors in a porcine kidney cell line as in other mammalian cells (Luo et al., 2014; Zhou, Wen, Ringseis, & Eder, 2014) . Although OCTN2 expression in the kidney of avian species has not been investigated yet, it was shown that OCTN2 from chicken is also a highly specific carrier for L-carnitine (Grigat et al., 2009 ).
As L-carnitine is not excreted via the bile, L-carnitine in the faeces is composed mainly of dietary L-carnitine not being absorbed from the small intestine, L-carnitine from microbial synthesis in the large intestine and inevitable losses of L-carnitine. Considering the high L-carnitine absorption rate of >90%-95% in the small intestine of pigs (Fischer, Varady et al., 2009) , it can be assumed that the proportion of non-absorbed L-carnitine entering the large intestine is <5%-10% of the amount ingested, at least in pigs. Whether this is similar in poultry cannot be answered, because studies determining intestinal L-carnitine absorption rate in poultry are lacking. However, one should be cautious about assuming similar L-carnitine absorption rates for pigs and poultry, because great differences in intestinal L-carnitine absorption rates are known even within different mammals, for example pigs vs. rats and humans (Evans & Fornasini, 2003; Harper, Elwin, & Cederblad, 1988; Ringseis, Lüdi, Hirche, & Eder, 2008) . The inevitable L-carnitine losses even occur when the diet is devoid of L-carnitine and represent cellular L-carnitine from desquamation of intestinal epithelial cells. Although data on inevitable losses of L-carnitine in pigs and poultry are also missing, their contribution to faecal L-carnitine excretion is likely negligible. This assumption is based on an own study in rats, in which praecaecal L-carnitine absorption rate of L-carnitine was determined by the indicator method (Ringseis, Lüdi et al., 2008) , and the concentration of L-carnitine in the ileal chyme of a subgroup of rats fed a L-carnitinedeficient diet was found to be approximately 0.005% of DM (data not published). Likewise, no data exist with regard to the extent of microbial L-carnitine synthesis in the large intestine of pigs and poultry.
However, it is well known that L-carnitine is required by many bacteria as an osmoprotectant and/or osmolyte and to protect against different conditions of stress, such as bile stress, low-temperature stress and high pressure (Meadows & Wargo, 2015) . Due to this, bacteria either take up L-carnitine from extracellular sources or synthesize L-carnitine endogenously from direct precursors, such as free TML (Barbier et al., 2013) or γ-BB (Lindstedt, Lindstedt, & Tofft, 1970) . However, L-carnitine is also utilized by bacteria as a carbon or nitrogen source and is therefore enzymatically degraded by bacteria. This leads to formation of trimethylamine (TMA) and malic semialdehyde, the latter being rapidly converted to malic acid which enters the tricarboxylic acid cycle. Formation of TMA by gut bacteria from dietary L-carnitine has gained great attention and triggered an intense debate in the scientific community, because intestinal microbiota metabolism of exogenous L-carnitine to TMA, which is subsequently oxidized by flavin-dependent monooxygenases in the liver to the proatherogenic species TMA-N-oxide (TMAO; Bennett et al., 2013) , was shown to promote atherosclerosis in several independent studies (Koeth et al., 2013; Kuka et al., 2014 ). An alternative metabolic route for L-carnitine to be utilized as carbon source is the multistep metabolism to glycine betaine, which is then successively demethylated to glycine that can be utilized as carbon, nitrogen and energy source depending on the bacterial strain. In order to be used as a sole nitrogen source, glycine which is formed via the glycine betaine route, is converted to serine followed by deamination to form pyruvate and ammonia (Meadows & Wargo, 2015) . This indicates that at least a small proportion of L-carnitine in the faeces, which has not been utilized by bacteria in the large intestine, is derived from bacterial L-carnitine synthesis. However, its contribution to faecal L-carnitine content cannot be specified.
In mammals, L-carnitine is also excreted via the milk during lactation. Particularly in high-yielding sows, provision of L-carnitine to the milk represents a significant drain of L-carnitine from the body's L-carnitine pool considering that the output of milk, which is rich in L-carnitine, is high and the L-carnitine concentration in the liver and plasma was found to be approximately 20% and 50%, respectively, lower in lactating sows suckling 12 piglets/sow than in non-lactating sows. In this context, it is interesting that total L-carnitine concentration in the milk of sows was increased by 24% in response to feeding 50 mg supplemental L-carnitine/kg diet during lactation (Musser, Musser, Goodband, Tokach, Owen, Nelssen, Blum, Campbell et al., 1999) . In another study, feeding of 250 mg supplemental L-carnitine/ kg diet during pregnancy and lactation resulted in a 35% increase of total L-carnitine concentration in the milk of sows (Ramanau, Kluge, Spilke, & Eder, 2004) . Thus, supplementation of L-carnitine to sows during pregnancy and lactation might be a reasonable means to preserve the body's L-carnitine stores. In addition, piglets suckled from sows supplemented with L-carnitine during lactation obviously profit from the increased supply of L-carnitine with the milk as indicated from elevated plasma concentrations of L-carnitine in these piglets .
In poultry, L-carnitine is also excreted via the production of eggs as in laying hens. This is based on the observation that feeding of supplemental L-carnitine to laying hens (50 and 100 mg/kg diet) increased total L-carnitine concentration of egg white by 33% and 95%, respectively, and of egg yolk by 26% and 45% respectively (Richter, Schlumbohm, Baumgartner, & Ochrimenko, 1998) . Although systematic studies in laying hens investigating changes of L-carnitine status in different organs during the laying period are lacking, it can be assumed that egg production is accompanied by a mobilization of the L-carnitine stores of laying hens. However, it is also possible that as a compensatory means endogenous L-carnitine biosynthesis is stimulated in laying hens during the laying period.
| REG UL ATI ON OF L-C ARNITINE S TATUS IN PI G S AND P OULTRY

| Response of L-carnitine status to dietary Lcarnitine
Several studies in both pigs and poultry clearly show that supplementation of dietary L-carnitine markedly increases plasma Lcarnitine concentration Fischer, Varady et al., 2009; Leibetseder, 1995) , which is indicative of high bioavailability of L-carnitine in the diet in monogastric farm animals. As stated in the section above, data on the intestinal L-carnitine absorption rate are only available for pigs. In one study with young growing pigs, it was demonstrated that small levels of supplemental L-carnitine (25, 50 and 100 mg/kg diet) are almost completely absorbed (>95%), but also high levels of supplemental L-carnitine are absorbed at high rates (>90%; Fischer, Varady et al., 2009) . After a 20-day-feeding period, the concentration of total L-carnitine in plasma of the pigs was dose dependently increased up to 5.1-fold at the highest level of supplemental L-carnitine in the diet (1000 mg/ kg diet; Fischer, Varady et al., 2009) . Apart from plasma L-carnitine, tissue L-carnitine concentrations show a marked response to supplementation of dietary L-carnitine in pigs Fischer, Varady et al., 2009; Kaup et al., 2018; Keller et al., 2011; Ramanau et al., 2004) . For instance, in the abovementioned study with growing pigs (Fischer, Varady et al., 2009) , the concentration of total L-carnitine in skeletal muscle, liver, kidney and heart was increased with increasing level of supplemental Lcarnitine and reached the 3.6-5.6 fold of that of non-supplemented control pigs at a L-carnitine concentration of 1000 mg/kg diet. The marked increase of skeletal muscle L-carnitine concentration in response to supplemental L-carnitine in pigs is in strong contrast to that seen in several other species including humans (Barnett et al., 1994; Wächter et al., 2002) , rats (Lambert, Dobson, Cherry, & Sanderford, 2009; Ringseis, Lüdi et al., 2008) and cattle (LaCount et al., 1995) . In the latter species, skeletal muscle L-carnitine concentration was found to exhibit either a weak response or no response at all to even high doses of supplemental Lcarnitine. One reason that might account for this species specificity of the pig is the high rate of intestinal L-carnitine absorption in pigs compared to humans or rats (<40%; Evans & Fornasini, 2003; Harper et al., 1988; Ringseis, Lüdi et al., 2008) . However, this reason does not sufficiently explain that i.v.-infusion of L-carnitine in humans failed to affect muscle L-carnitine concentration. Thus, it is possible that the skeletal muscle's capacity to take up L-carnitine from plasma is higher in pigs than in the other species mentioned. This could be explained by a higher expression of level of OCTN2 in skeletal muscle of pigs compared to the other species, which, however, remains to be shown.
Although limited information is available with regard to the response of tissue L-carnitine concentrations to dietary L-carnitine in poultry, the few studies available demonstrate that L-carnitine concentrations in skeletal muscle, liver, kidney and heart are significantly elevated by supplemental dietary L-carnitine in broilers (Leibetseder, 1995) . In addition, supplemental dietary L-carnitine was also found to increase egg concentration of free and total L-carnitine by twoto threefold in laying hens fed a diet supplemented with 100 mg Lcarnitine/kg diet (Richter et al., 1998) .
| Physiologic regulation of L-carnitine status by nutrient sensing nuclear receptors
Nutrient sensing describes the ability to sense and respond to variations in environmental nutrient supply. Considering that nutrient scarcity is critical for the survival of each individual, organisms including animals have evolved efficient signalling mechanisms that sense the shortage of nutrient supply and translate this signal into a rapid physiologic response that triggers homoeostatic mechanisms, such as mobilization of energy stores, enabling the organism to survive (Efeyan et al., 2015; Lee et al., 2014; Preidis et al., 2017) . A key role in nutrient sensing at the interface between environment and genome is played by different nuclear receptors which, in general, are able to sense changes in the cellular and whole-body nutrient supply and translate this signal into a physiologic response via affecting gene transcription. In the context of regulation of L-carnitine status, a large body of recent evidence suggests that L-carnitine status in animals is subject to regulation by peroxisome proliferator-activated receptors (PPARs; Ringseis et al., 2012) , which is one representative of the nutrient sensing nuclear receptors (Preidis et al., 2017 in rodents during fasting (Brass & Hoppel, 1978; McGarry, RoblesValdes, & Foster, 1975) . These observations already indicated that hepatic L-carnitine concentration is regulated by nutrient scarcity, but the underlying mechanisms remained obscure for a long time. It took more than two decades until convincing evidence was provided from studies with rodents and genetic studies that activation of a specific PPAR isotype, PPARα, during fasting is responsible for this phenomenon (Koch, König, Stangl, & Eder, 2008; Luci et al., 2006; van Vlies, Ferdinandusse, Turkenburg, Wanders, & Vaz, 2007; Wen et al., 2010) . PPARα has been first identified in the early 1990s and later named "fasting regulator," because PPARα-through acting as a ligand-activated transcription factor-induces a comprehensive metabolic programme comprising fatty acid oxidation, gluconeogenesis and ketogenesis with the aim of providing energy substrates to tissues, thereby, ensuring survival of the organism during prolonged fasting (Kersten et al., 1999) . In addition, PPARα stimulates autophagy (Lee et al., 2014) , which is an evolutionary conserved catabolic process recycling nutrients in response to fasting (Rabinowitz & White, 2010) . The critical role of PPARα in the fasting response is most impressively demonstrated in PPARα-knockout mice, which display no obvious phenotype when fed, but become severely steatotic, hypoglycaemic and hypoketonaemic when fasted (Kersten et al., 1999) . The above-mentioned rodent studies and genetic studies unequivocally demonstrated that PPARα activation also stimulates hepatic L-carnitine uptake and endogenous L-carnitine biosynthesis, because genes encoding the L-carnitine transporter OCTN2 and two enzymes of the L-carnitine biosynthetic pathway, BBD and TMABA-DH, are directly regulated by PPARα (Wen, Kühne, Rauer, Ringseis, & Eder, 2011; Wen, Ringseis, Rauer, & Eder, 2012; Wen et al., 2010) . Accordingly, in PPARα-knockout mice basal (nonfasted) tissue L-carnitine concentrations are significantly reduced when compared to wild-type mice (Koch et al., 2008 ) and fasting does not increase hepatic L-carnitine concentration in contrast to wild-type mice (van Vlies et al., 2007) .
PPARα-mediated stimulation of L-carnitine uptake and synthesis during fasting fits well into the comprehensive fasting-induced metabolic program aiming to provide ATP from fatty acid oxidation and alternative energy substrates to the brain (ketone bodies). In fact, Lcarnitine is intrinsically linked to mitochondrial fatty acid β-oxidation and generation of ketone bodies from acetyl-CoA, because the formation of fatty acyl-L-carnitine esters is required for the translocation of the fatty acids from the cytosol into the mitochondrial matrix for subsequent fatty acid β-oxidation, that is L-carnitine acts as the shuttling molecule for fatty acids (Fritz, 1959) . Thus, PPARα-mediated increase in tissue L-carnitine concentrations in metabolic tissues utilizing fatty acids (liver, skeletal muscle, kidney) serves to provide sufficient shuttling molecules required for the increased import of fatty acids into the mitochondria. Importantly, PPARα is not only involved in the regulation of hepatic L-carnitine concentration, but also regulates whole-body L-carnitine homoeostasis through stimulating OCTN2-mediated intestinal L-carnitine absorption from the diet (Ringseis, Lüdi et al., 2008) and OCTN2-mediated renal Lcarnitine reabsorption from the urine (van Vlies et al., 2007) . This is explained by the fact that OCTN2 in these tissues, like in the liver, is also regulated in a PPARα-dependent manner as shown in wholebody PPARα-knockout mice (Koch et al., 2008) .
Activation of hepatic PPARα during fasting is widely considered to be caused by free fatty acids, which are released into the circulation by hydrolysis of stored triglycerides in white adipose tissue (WAT)-an early hormonally (glucagon, catecholamines)-triggered event during fasting-and extensively taken up by the liver (Kersten et al., 1999) . Indeed, several in vitro studies demonstrated that free fatty acids, particularly unsaturated ones, are potent PPARα ligands (Forman, Chen, & Evans, 1997) suggesting that free fatty acids are the endogenous ligands of PPARα which upon binding induce the effect of PPARα on gene transcription. Indeed, oleic and linoleic acid were found to accumulate in the liver of hepatocyte-specific PPARα-knockout mice (Montagner et al., 2016) , which is in line with the fact that both fatty acids are the main fatty acids stored in WAT of mice (Chakravarthy et al., 2005) . In addition, there is a high correlation between the kinetics of circulating free fatty acid increase and hepatic expression of PPARα-target genes in wild type but not in hepatocyte-specific PPARα-knockout mice (Montagner et al., 2016) . Moreover, it was reported that treatment of fasted mice with a β3-adrenergic receptor agonist enhances circulating free fatty acid levels and increases hepatic expression of PPARα-target genes in wild-type mice, but not in hepatocyte-specific PPARα-knockout mice (Montagner et al., 2016 (Feldman, Lambert, & Henke, 2008; Forman et al., 1997) . In line with this, treatment of rodents with fibrates mimics the typical fasting response and increases tissue L-carnitine concentrations (Paul & Adibi, 1979 ) and expression of genes involved in L-carnitine synthesis and uptake (Luci et al., 2006; Ringseis, Pösel, Hirche, & Eder, 2007) .
In line with the view that PPARα-mediated increase in tissue L-carnitine concentrations in metabolic tissues utilizing fatty acids (liver, skeletal muscle, kidney) serves to facilitate the increased shuttling of fatty acids into the mitochondria, plasma free L-carnitine was shown to decrease or to be extracted by tissues during acute exercise in man (Broderick, Poirier, Tremblay, Catellier, & Nadeau, 1989; Carlin, Reddan, Sanjak, & Hodach, 1986; Lennon et al., 1983 ) and mice (Broderick, Cusimano, Carlson, & Tamura, 2017) . This is likely explained by the fact that during acute exercise, the demand for fatty acids is increased to support the increased metabolic activity of tissues (skeletal muscle, heart, liver) and this in turn increases the demand for L-carnitine in these tissues. Following an acute exercise, plasma L-carnitine level is replenished during the post-exercise period by stimulating endogenous L-carnitine biosynthesis and reabsorption of L-carnitine from the urine as reported from Broderick et al. (2017) . Interestingly, it has been also found that chronic exercise training for 10 weeks causes significant adaptations of L-carnitine homeostasis, namely a stimulation of L-carnitine biosynthesis and L-carnitine reabsorption in liver and kidney, in rats (Broderick et al., 2011; Ringseis, Mooren et al., 2011 Carmichael, 1996) . While in rodents fibrates cause a marked peroxisome proliferation and peroxisomal enzyme induction in the liver, those effects are much less pronounced in the liver of pigs, humans and non-human primates (Ammerschlaeger et al., 2004; Cattley et al., 1998) . This distinct response to PPARα activators accounts for the classification of different species into proliferating (rodents) and non-proliferating ones and has been explained by species differences with regard to expression level of PPARα, degree of conservation and functionality of the PPARα-sensitive cis-acting element, called PPRE, in the regulatory region of target genes, and expression levels of transcriptional co-regulators, such as CBP/p300, SRC-1-3, PGC-1α and PGC-1β (Yu & Reddy, 2007) . Based on the knowledge about these species differences, it has been also studied whether L-carnitine homoeostasis is regulated by PPARα in pigs. In a first study with pigs, the hypothesis was tested that treatment with a pharmacologic PPARα activator influences L-carnitine homeostasis in the pig (Ringseis, Luci et al., 2008) . To this end, 8-week-old crossbred pigs were fed a corn-soya bean meal-based diet without (control) or with 5 g/kg diet of clofibrate for 4 weeks. The study showed that classical PPARα-target genes were induced approximately 1.7-to 2.4-fold in the liver by clofibrate being indicative of moderate PPARα activation. In addition, the study showed for the first time that the L-carnitine transporter OCTN2 is up-regulated by clofibrate in liver, skeletal muscle and small intestine in pigs and this was accompanied by increased concentrations of free L-carnitine in plasma, liver and skeletal muscle (+19%-23%). To strengthen this finding that
PPARα plays a role in the regulation of L-carnitine homeostasis in pigs, a further study was carried out, in which 10-week-old crossbred pigs were either fed ad libitum or fasted for 24 hr to cause activation of PPARα (Ringseis et al., 2009 ). This study showed that fasting-induced activation of PPARα not only induced OCTN2 in liver, skeletal muscle and small intestine, but also in the kidney and heart (not significant) of the pigs. In addition, fasting of the pigs was accompanied by an increase in the concentration of free L-carnitine in liver (+67%), kidney (+47%) and skeletal muscle (+11%). Moreover, this study revealed that fasting causes an increase in the activity of BBD, the enzyme catalysing the last step of L-carnitine biosynthesis, in liver and kidney. The results of both studies provided strong indication that activation of PPARα induced either by pharmacologic activators or physiologically during fasting mediates an increase in tissue L-carnitine concentrations by stimulating OCTN2-mediated Lcarnitine uptake and endogenous L-carnitine synthesis.
Activation of PPARα in the liver has been demonstrated also in response to the feeding of oxidized fats, which are formed during cooking, baking and deep-frying, in rats and pigs Ringseis, Muschick, & Eder, 2007; Sülzle, Hirche, & Eder, 2004) . The reason for this is that oxidized fats contain hydroxy and hydroperoxy fatty acids, like 9-or 13-hydroxy octadecadienoic acid and 13-hydroperoxy octadecadienoic acid, which have been identified as potent activators of PPARα . Interestingly, feeding experimentally produced oxidized fats to pigs was also shown to increase the expression of OCTN2 in liver and/or small intestine (Koch, König, Luci, Stangl, & Eder, 2007; Varady, Ringseis, & Eder, 2012) and to increase hepatic L-carnitine concentration by approximately 50% (Koch et al., 2007) . It is therefore not unlikely that this effect of dietary oxidized fats on L-carnitine status of pigs is caused by the PPARα-activating effect of such fats, even though the evidence is largely indirect.
Convincing evidence for direct regulation of OCTN2 by PPARα in pigs was provided by a study from Luo et al. (2014) (Luo et al., 2014) . Due to the fundamental role of OCTN2 for tissue distribution, intestinal absorption and renal reabsorption of L-carnitine and thus L-carnitine homoeostasis, the study from Luo et al. (2014) confirmed the indications from in vivo studies (Ringseis, Luci et al., 2008; Ringseis et al., 2009 ) that PPARα is a key regulator of L-carnitine homoeostasis in pigs. Whether the porcine genes encoding enzymes involved in L-carnitine biosynthesis, such as BBD or TMABA-DH, are also direct PPARα genes has not been experimentally shown yet, but the results from in vivo studies are strongly supportive of this.
Noteworthy, besides fasting, lactation is a state during which PPARα is physiologically activated in the liver of pigs. This was indicated by genome-wide transcript profiling in the liver of lactating compared with non-lactating sows (Rosenbaum et al., 2012) , according to which a large set of known PPARα-target genes involved in fatty acid activation, fatty acid β-oxidation, fatty acid hydroxylation and the L-carnitine shuttle system were found to be up-regulated in lactating sows. The reason for this is that lactating sows are in a strong negative energy balance (NEB) because the high energy demand for milk production cannot be fully covered by feed intake. Accordingly, lactating sows show a significant loss of body weight during lactation (Rosenbaum et al., 2012) , which is at least partially attributed to a pronounced mobilization of stored energy depots (triglycerides) in adipose tissue thereby leading to elevated concentrations of free fatty acids in the circulation (Père & Etienne, 2007; Ringseis, Heller, Kluge, & Eder, 2011; Rosenbaum et al., 2012; Trottier & Easter, 1995) . 
| Evidence for regulation of L-carnitine homeostasis by nutrient sensing nuclear receptor PPARα in poultry
In contrast to mammalian species, systematic research on the regulation of L-carnitine status in poultry is missing in the literature.
Nevertheless, convincing evidence exists that PPARα in poultry plays, at least, a similar role as in mammals. In broiler chickens, PPARα shows a similar tissue distribution than in rodents and humans and is abundantly expressed in the liver (Diot & Douaire, 1999; Meng, Li, Zhao, & Gu, 2005) . In addition, several studies in chickens demonstrated that short-term fasting intervals between 4 and 24 hr cause an induction of genes involved in fatty acid transport and activation, fatty acid oxidation, ketogenesis and gluconeogenesis in the liver (Désert et al., 2008; Saneyasu, Shiragaki, Nakanishi, Kamisoyama, & Honda, 2013; Skiba-Cassy et al., 2007) -responses which are typical for hepatic PPARα activation in mammals. Moreover, in laying hens, it was shown that treatment with pharmacologic PPARα activators, such as fibrates, causes an induction of typical PPARα-target genes in the liver and exerts strong plasma lipidlowering effects (Mori, Mendonça, & Santos, 1999) . The latter effect is a consequence of PPARα-stimulated fatty acid catabolism in the liver (Kersten et al., 1999) and has been shown in numerous studies in mammalian species, such as mice, rats and pigs ).
The first indication of a role of PPARα in regulating L-carnitine homoeostasis in poultry was provided from the above study (Désert et al., 2008) , in which changes in the hepatic transcriptome of broiler to laying hens (Lohmann White layers) for 4 weeks and determined the tissue concentrations of free and total L-carnitine . Laying hens were used for this study, because an earlier study in laying hens had demonstrated that clofibrate (0.5% of the diet) causes strong PPARα activation in the liver and exerts pronounced triglyceride-lowering effects in liver, plasma and very low-density lipoprotein (VLDL) particles . As a consequence of the strong triglyceride-lowering effect of 5 g clofibrate/kg diet in the study of König et al. (2007) , the hens completely stopped egg production, because plasma VLDL particles bound to oocyte receptors are essentially required for lipid filling of follicles and egg yolk formation (Walzem, Hansen, Williams, & Hamilton, 1999) .
To avoid such confounding effects, which would have not allowed studying the effect on L-carnitine status of laying hens, we have used only 1.5 g clofibrate/kg diet, a dose sufficient to cause activation of PPARα but without induction of confounding effects . According to our hypothesis that PPARα activation increases tissue and egg concentrations of L-carnitine in laying hens, clofibrate administration caused marked increases of total L-carnitine in liver (+50%), muscle (+20%), plasma (+40%) and whole egg (+77%). The increased hepatic L-carnitine concentration by clofibrate in laying hens was accompanied by an up-regulation of hepatic OCTN2, the physiologically most important L-carnitine transporter. Because OCTN2 has been identified as a PPARα-target gene in several mammalian species including pigs, mice, rats and cattle, it is likely that clofibrate stimulated OCTN2-mediated L-carnitine uptake from plasma into the liver of laying hens. Considering that endogenous L-carnitine synthesis, which takes place mainly in the liver, is also stimulated by PPARα activation, at least in mice, rats, cattle and pigs , it is also possible that an increased L-carnitine synthesis has contributed to the elevated hepatic L-carnitine concentration in clofibrate-treated laying hens. PPARα-mediated stimulation of L-carnitine synthesis is explained by the fact that genes involved in L-carnitine synthesis, such as BBD and TMABA-DH, are direct PPARα-target genes, at least in mice . In contrast to fasting-induced up-regulation of hepatic BBD in broiler chickens (Désert et al., 2008) , however, the hepatic mRNA level of BBD did not differ between clofibrate treated and control laying hens suggesting that clofibrate treatment had no effect on endogenous L-carnitine synthesis, at least in laying hens ).
Another possibility is that an increased OCTN2-mediated renal operates on intestinal L-carnitine absorption in birds (Durán et al., 2002) . However, in the case that intestinal OCTN2-mediated Lcarnitine absorption had been stimulated by clofibrate in laying hens of the study from , its contribution to the elevation of plasma L-carnitine levels in the laying hens is uncertain. This is attributed to the fact that the L-carnitine concentration of the layer diet fed was presumably low, because it consisted mainly of plant-based components (wheat, soya bean meal, maize, peas), which have a low L-carnitine content. The increased egg concentration of L-carnitine in laying hens receiving clofibrate is indicative of an increased OCTN2-mediated L-carnitine transport across the oocyte membrane. However, this is also a matter of speculation regarding that OCTN2 expression in the oocyte membrane has not
been described yet in any species. To sum up, although the precise mechanisms underlying increased tissue and egg concentrations of L-carnitine in laying hens need to be unravelled, the findings from suggest that PPARα plays an important role in regulating L-carnitine status in poultry like in mammalian species.
In a further study from C20-and C22 n-3 polyunsaturated fatty acids (PUFA). However, following a feeding period of 4 weeks, no effect of the different dietary fats was found on free and total L-carnitine concentrations in liver, skeletal muscle, plasma and whole egg. This indicated that nutritive PPARα agonists, unlike pharmacologic PPARα agonists, are
obviously not able to alter the L-carnitine status of laying hens. One explanation might be that the binding affinity of PPARα for unsaturated fatty acids like n-3 PUFA and CLA isomers is generally weaker when compared to pharmacologic PPARα activators (Forman et al., 1997) . This was indicated by the mainly unaltered mRNA levels of PPARα-target genes in the liver between laying hens fed either fish oil or CLA-oil and the control group. However, it should be also taken into account that the diet of the control hens contained 30 g/kg diet of sunflower oil instead of fish oil and CLA-oil, respectively, and the sunflower oil contained approximately 55% linoleic acid. Linoleic acid is also known to bind to and activate PPARα (Forman et al., 1997) , albeit to a lower degree than n-3 PUFA or CLA isomers. It is therefore possible that the activity of hepatic PPARα has been activated also in control laying hens. One might speculate that the L-carnitine status of laying hens is improved by fish oil or CLA-oil when compared to a dietary fat containing either no or only marginal levels of PUFA and CLA isomers, such as coconut oil.
| EFFIC AC Y OF L-C ARNITINE SUPPLEMENTATI ON ON PERFORMAN CE OF MONOG A S TRIC FARM ANIMAL S
| Poultry
| Broiler chickens
Despite marked improvements in broiler performance via artificial selection for improved feed use efficiency in the recent decades (Tallentire, Leinonen, & Kyriazakis, 2016) , there is still a need for optimization of feeding regimes in modern chicken broiler breeds because important quality traits such as carcass fatness, which is considered unfavourable by the customer in the case that it is high, are strongly affected by dietary factors. Due to the involvement of L-carnitine in fatty acid β-oxidation and other important metabolic pathways, a large number of studies have been performed investigating the effect of supplemental L-carnitine on performance and quality traits in broiler chickens. 
It is obvious from this overview that the study outcomes are very inconsistent. Beneficial effects of L-carnitine supplementation have been observed in a series of studies from Rabie, Szilágyi, and Gippert (1997a), Rabie, Szilágyi, Gippert, Votisky, and Gerendai (1997) and Rabie and Szilágyi (1998) . In the study Rabie, another study with Ross broilers (Rabie, Szilágyi, & Gippert, 1997a) that L-carnitine supplementation (0 and 50 mg/kg diet) from day 18 to 53 of age in combination with different levels of crude protein (18%, 20% and 22%) increases BW gain and gain-to-feed ratio and decreases the contents of abdominal fat and crude lipids of breast meat in 53-day-old broilers regardless of the level of crude protein in the diets. In a further study of Rabie and Szilágyi (1998) , in which the effect of supplemental L-carnitine (0 and 50 mg/ kg diet) from day 18 to 53 of age in combination with different dietary metabolizable energy levels (12.2, 12.8 and 13.5 MJ/kg diet) was investigated, it was demonstrated that supplemental L-carnitine increases BW gain and improves gain-to-feed ratio of Hybro broiler chickens during the first 2 weeks of the study (day 18-32 of age). In addition, supplemental L-carnitine elevated breast yield and thigh meat yield, whereas quantity and percentage of abdominal fat was reduced by supplemental L-carnitine.
Apart from the studies from Rabie and co-workers, a beneficial effect of supplemental L-carnitine on broiler chickens performance was reported from Kita, Kato, Amanyaman, Okumura, and Yokota (2002) . In this study, the effect of different levels of supplemental L-carnitine (0, 200, 500 and 1000 mg/kg diet) in combination with different dietary protein levels (50, 200 and 400 g/kg) fed from day 7 to 17 was studied in male White Leghorn chickens (n = 200). Although L-carnitine supplementation at 500 mg/ kg diet and above was shown to improve BW gain of the White
Leghorn chickens in this study, it is noteworthy that the effective dietary L-carnitine concentration was 10-fold higher than in the studies from Rabie et al. (1997a) , Rabie, Szilágyi, Gippert, Votisky et al. (1997) and Rabie and Szilágyi (1998) . It is tempting to speculate if this is due to the different chicken breeds used by Kita et al. (2002) and Rabie et al. (1997a) , Rabie, Szilágyi, Gippert, Votisky et al. (1997) and Rabie and Szilágyi (1998) . Interestingly, Kita et al. At least partially beneficial effects of supplemental L-carnitine on growth performance of broiler chickens were reported by two studies from Celik, Oztürkcan, Inal, Canacankatan, and Kayrin (2003) and . In the study from , BW gain and feed intake of COB500 broiler chickens was improved by In another study from this group , the effect of two levels of supplemental L-carnitine (0 and 50 mg/kg diet) in combination with ascorbic acid (0 or 500 mg/kg diet), which is a known co-factor of endogenous L-carnitine synthesis, was studied in Ross broiler chickens reared under thermoneutral (20-22 degrees C for 24 hr) or high temperature conditions (34-36 degrees C for 8 hr and 20-22 degrees C for 16 hr). The high temperature conditions were applied to induce heat stress, which is known to impair growth performance of chicken broilers due to reduced feed intake and increased energy consumption for thermoregulation (Khan, Naz, Nikousefat, & Selvaggi, 2012) . Remarkably, the authors observed that BW gain of chickens is improved by supplemental L-carnitine alone and in combination with ascorbic acid under high temperature conditions indicating that supplemental L-carnitine has beneficial effects under conditions of heat stress . In contrast, in a recent study from Rehman, Chand, and Khan (2017) , supplemental L-carnitine (500 mg/kg diet) failed to improve gain-tofeed ratio of two strains of broiler chickens (Hubbard, n = 160; Cobb n = 160) exposed to heat stress (natural high sommer temperature) for 4 weeks from day 14 of age, despite supplemental L-carnitine increased feed intake of broiler chickens.
In most of the studies dealing with the effects of supplemental L-carnitine in broiler chickens, no improvement of performance parameters was observed. To the best of our knowledge, Barker and Sell (1994) were the first to report that supplemental L-carnitine is ineffective in improving performance (BW gain, gain-to-feed ratio)
and carcass composition of broiler chickens. In this study, the effect of three levels of supplemental L-carnitine (0, 50 and 100 mg/ kg diet) at two levels of fat (10 and 50 g/kg diet) was investigated in a feeding trial with male Hubbard purebred broiler chickens (n = 240)
from day 1 to 45 of age. Also, Leibetseder (1995) found no influence of supplemental L-carnitine on both, performance (BW gain and gain-to-feed ratio) and carcass quality (abdominal fat) of broiler chickens. Likewise, in the study of Mast, Buyse, and Goddeeris muscle. This should be taken into account, because it is well-known from certain species, such as rats and humans, that even high doses of supplemental L-carnitine cause either no or only a slight increase of muscle L-carnitine concentration (Barnett et al., 1994; Ringseis, Lüdi et al., 2008) . In contrast, in pigs the muscle L-carnitine concentration shows a marked response to supplemental L-carnitine (Fischer, Varady et al., 2009; Kaup et al., 2018; Keller et al., 2011) .
Future studies have to clarify if broiler chickens are "hyper"-(e.g., pigs)-or "hypo"-responders (e.g., rats, humans) to supplemental Lcarnitine. In any case, the frequently expressed view that L-carnitine biosynthesis in young broiler chickens is generally limited cannot be maintained, because several studies with 1-day-old broiler chickens reared with commercial starter diets, which typically exhibit a very low L-carnitine content (<10 mg/kg diet), did not exhibit a beneficial effect of supplemental L-carnitine on growth performance.
| Laying hens
Apart from genetics (breed, strain of the birds), age and housing conditions, nutrition belongs to the most important factors influencing performance and egg quality in laying hens (Moreng & Avens, 1985) . Thus, numerous studies have been conducted investigating the efficacy of feed additives in improving performance and egg quality traits in laying hens. However, with regard to the efficacy of L-carnitine supplementation only few studies have been performed, which are summarized in Table 2 .
The first study on this topic revealed no effect of supplemental L-carnitine (0 or 500 mg/kg diet) included in a commercial standard layer ration with two levels of niacin (0 or 500 mg/kg diet) on growth and laying performance of laying hens (strain, n), but reported an increase of egg yolk percentage in the L-carnitinesupplemented groups (Leibetseder, 1995) . In line with this, in another study, no effect of feeding different levels of supplemental L-carnitine (0, 50, 100 or 500 mg/kg diet) included in a practical maize-, soy-and wheat-based layer diet for 8 weeks was observed on performance (egg production rate, mean egg weight, daily feed intake, daily egg mass, feed efficiency) of laying hens (9-week-old Tetra SL laying hens, n = 40; Rabie, Szilágyi, & Gippert, 1997b ). In addition, external egg quality parameters (shell breaking strength, shell thickness, shell weight per unit egg surface area) were not affected by supplemental L-carnitine. However, albumen quality, an internal egg quality parameter, was dose dependently improved by supplemental L-carnitine; for example albumen height and Haugh unit score as well as absolute and relative albumen weights were increased. Other internal egg quality parameters such as yolk index and yolk colour score were not affected by supplemental L-carnitine. Rabie et al. (1997b) speculated that the effect of supplemental L-carnitine on the egg albumen (weight and quality) is due a stimulation of the metabolic activity of the magnum, which is responsible for the secretion of β-ovomucin, a gelatinous protein of the thick-egg-white, and/or a higher activity of the shell gland. In contrast to the results from Leibetseder (1995) , supplemental L-carnitine at a concentration >50 mg/kg diet decreased absolute and relative yolk weights, effects which have been attributed to a reduction in the synthesis of yolk precursors, in particular yolk lipids, in the liver and/or an impaired transport of these yolk precursors from the liver into the ovarian follicle and the oocyte. In addition, Richter et al. (1998) demonstrated no effect of supplemental L-carnitine (0, 50 or 100 mg/kg diet) provided in a diet consisting of wheat, maize, barley, soya bean meal and 5%
animal meal on laying performance of ZEH's Braune Warren laying hens (n = 378) from weeks 44-72 of age. No effect on laying performance (feed intake, egg mass, egg weight, egg production)
was also observed in a study from Corduk and Sarica (2008) , in which the effects of supplemental L-carnitine (0 or 500 mg/kg diet) was investigated in a 2 × 2 × 3 factorial design with two levels of metabolizable energy and three sources of dietary fat in 27-week-old Isabrown laying hens (n = 180). In addition, most egg quality traits were not influenced by the supplemental L-carnitine.
In a further study, in which the effect of supplemental L-carnitine (0 or 150 mg/kg diet) was investigated in the late laying period (62-72 weeks of age) of 62-week-old Nick Chick white laying hens (n = 96), also no effect was found on performance (egg production, feed intake, feed conversion) and internal and external egg quality parameters (Daskiran, Onol, Cengiz, Tatli, & Sari, 2009 ). In another study from a Turkish group (Güçlü, Kara, Çakır, Çetin, & Kanbur, 2011) , the effect of supplemental L-carnitine (0 or 400 mg/kg diet) was investigated on performance, egg quality and certain biochemical parameters in 42-week-old Bovans laying hens (n = 48) fed a diet with two levels copper proteinate (CuP; 0 or 800 mg/kg diet) for 6 weeks. Like in the studies from Leibetseder (1995) and Rabie et al. (1997b) , supplemental L-carnitine alone had no effect on performance parameters (egg production, feed efficiency, egg weight) of the laying hens. However, supplemental L-carnitine increased egg shell thickness, a parameter of external egg quality (Güçlü et al., 2011) . In contrast to supplementing L-carnitine alone, supplemented hens. However, it is obvious from this study that the laying performance was relatively low, which is probably due to the advanced age of the hens. It is therefore possible that supplemental L-carnitine has a positive effect on performance of laying hens only during advanced age. An explanation for this might be that the rate of endogenous L-carnitine biosynthesis is decreasing with increasing age.
Collectively, the vast majority of studies in laying hens convincingly show that supplemental L-carnitine is ineffective in improving growth and/or laying performance of laying hens when fed standard layer rations. However, supplemental L-carnitine may improve performance of laying hens under conditions of diet-induced stress, such as high levels of prooxidant trace elements, and at advanced age of the laying hens.
| Pigs
| Gestating and lactating sows
Development of feeding strategies such as supplementation of gestation and lactation feed with feed additives like L-carnitine to improve performance of sows are of great interest, because a high productivity of sows is key factor for the profitability of pig production. Productivity of sows is typically measured by the number of pigs weaned per sow and year (Koketsu, Tani, & Iida, 2017) , with the number of pigs weaned per sow being dependent on the number of piglets born alive and the preweaning mortality of suckling piglets.
Within the last 20 years, several studies have been published describing the effect of supplemental L-carnitine on performance characteristics of sows. Table 3 summarizes the most important aspects of these studies, namely the experimental design and the outcome.
In the first study published on this topic, the effect of feeding supplemental L-carnitine during gestation (0 or 100 mg/kg diet) and during lactation (0 or 50 mg/kg diet) was studied in multiparous sows (n = 307; Musser, Goodband, Tokach, Owen, Nelssen, Blum, Dritz et al., 1999) . This study revealed that supplemental L-carnitine given throughout gestation increases litter weights at birth and weaning and BW gain of sows, whereas the supplemental L-carnitine given during lactation had no effect. The lack of effect of supplemental L-carnitine fed during lactation on sow and litter performance was largely confirmed in a second study of Musser, Goodband, Tokach, Owen, Nelssen, Blum, Campbell et al. (1999) was observed in the L-carnitine-supplemented sows (Eder, Ramanau, & Kluge, 2001 ). In addition, piglets from L-carnitine-supplemented sows had higher BW gains during the suckling period. In a further study of our group (Ramanau, Kluge, Spilke, & Eder, 2002) , the effect of L-carnitine supplementation during pregnancy (125 mg/day) and lactation (250 mg/day) on the reproductive performance of sows was studied in two separate trials with n = 127 and n = 100 Leicoma sows, respectively, over three reproductive cycles. As in the study through one gestation, the following lactation, the interval from weaning to oestrus, and 28 days into the following gestation had increased plasma leptin concentrations, which may be indicative of an improved body condition and energy status. In agreement with this, another study from this group (Woodworth et al., 2007) demonstrated that gestating PIC C-22 sows (n = 44; parity = 2.0; BW = 208 kg) fed supplemental L-carnitine (0 or 50 mg/kg diet) had reduced plasma concentrations of NEFA, urea N, insulin and glucose indicating that energy mobilization of fatty acids from adipose tissue and of amino acids from skeletal muscle of sows was reduced while the energy status of sows was improved by the supplemental Lcarnitine. The sparing of metabolic substrates in sows receiving supplemental L-carnitine is also reflected by an increased BW and back fat thickness in L-carnitine-supplemented sows of the study from Musser, Goodband, Tokach, Owen, Nelssen, Blum, Dritz et al. (1999) and by higher BW gains of L-carnitine-supplemented sows between day 1 and 85 of gestation in our own study (Eder et al., 2001) . To clarify whether L-carnitine supplementation improves energy utilization in sows, the effect of Carnichrome, a combination of L-carnitine and chromium (50 mg L-carnitine and 200 μg chromium picolinate/ kg diet), was studied in n = 12 sows (Large White × Landrace, initial BW: 182 kg) for the preceding 28-day lactation, the weaning-tooestrus interval, and the subsequent gestation (Young et al., 2004) .
While the contents of digestible and metabolizable energy of the Carnichrome diet were indeed higher than those of the control diet, no effect was found on total heat production, energy retained as protein or lipid and maternal energy retention in early, mid-or late gestation. This indicated that improvements of reproductive performance by supplemental L-carnitine are not due to changes in heat production or energy retention.
Apart from improving sow's metabolism, maternal L-carnitine supplementation also influences the metabolism of the foetuses;
for example L-carnitine concentrations were also found to be increased in liver, skeletal muscle and heart of foetuses collected from L-carnitine-supplemented sows at day 55 and 70 of gestation Xi et al., 2008) Birkenfeld, Kluge, & Eder, 2006b) . In order to test the hypothesis that an improved suckling behaviour contributes to the increased postnatal growth, we performed two experiments with sows that were fed with or without supplemental L-carnitine during pregnancy (125 mg/day) and lactation (250 mg/day; Birkenfeld et al., 2006a) .
The first experiment of this study, in which litters were standardized to equal sizes, revealed that piglets of L-carnitine-supplemented sows had a higher total suckling time per day (on day 3, 6 and 9 of lactation), and greater BW gains during the suckling period than piglets of control sows. In the second experiment, all litters were removed from their mothers and then half of the control sows and half of the L-carnitine-supplemented sows received litters born to control sows and the other half of each group received litters born to Lcarnitine-supplemented sows. This experiment revealed that piglets born to L-carnitine-supplemented sows had a higher total suckling time per day and greater BW gains during the first 14 days compared with piglets born to control sows suggesting that piglets born to Lcarnitine-supplemented sows are able to obtain more milk and grow faster than piglets born to control sows. This clearly indicated that L-carnitine supplementation during lactation has no influence on the suckling behaviour and BW gains of litters. In agreement with this are findings from the above-mentioned studies from Musser, Goodband, Tokach, Owen, Nelssen, Blum, Campbell et al. (1999) and Musser, Goodband, Tokach, Owen, Nelssen, Blum, Dritz et al. (1999) . These studies revealed that weaning weights of litters born to sows fed supplemental L-carnitine during gestation are increased, whereas weaning weights of litters born to sows supplemented with L-carnitine during gestation, but not supplemented with L-carnitine during lactation are not altered. 
| Suckling piglets
A great challenge for further improvement of the number of pigs weaned per sow lies in the increasing selection for hyperprolific sows in pig production. Hyperprolific sows have increased litter sizes but decreased average birth weights of piglets (Foxcroft et al., 2009) , and therefore more piglets with low birth-weights (Beaulieu, Aalhus, Williams, & Patience, 2010; Rutherford et al., 2013) . The problem associated with this fact is that low-birth weight piglets compared with heavier littermates exhibit a reduced pre-and post-weaning growth (Deen & Bilkei, 2004; Madsen & Bee, 2015) and an increased pre-weaning mortality (Quiniou, Dagorn, & Gaudré, 2002) . In addition, low-birth weight piglets have a limited capacity for protein accretion due to a reduced number of myofibres at birth and to an impaired muscle maturation (Bérard, Pardo, Béthaz, Kreuzer, & Bee, 2010) , which promotes fat deposition and impairs carcass quality at market weight. Investigating potentially beneficial effects of supplemental L-carnitine in low-birth weight piglets through early weaning in combination with feeding a milk replacer supplemented with Lcarnitine is therefore of great relevance for improving profitability of pig production. Despite the high relevance of this topic, the number of studies dealing with the effect of L-carnitine supplementation in suckling or early-weaning piglets, in particular those with low-birth weights, is relatively low. Table 4 gives an overview about important facts on these studies.
In a study from Lösel, Kalbe, and Rehfeldt (2009) The piglets were exclusively suckling (no creep-feed was offered), and thus, no additional L-carnitine was taken up than from sow's milk. In a subsequent study from Lösel and Rehfeldt (2013) , in which low-birth weight piglets (n = 56 female and castrated male from 14
German Landrace sows) were orally supplemented with 400 mg Lcarnitine per day during the suckling period (from day 7 to 27 of age) and fed standard diets from weaning at day 28 of age until slaughter at day 166 of age, it was shown that growth performance, body composition, measures of meat yield and fat accretion and muscle contractile traits at slaughter were not influenced by supplemental L-carnitine. In contrast to the before-mentioned study of this group, piglets were offered creep-feed from day 10 of age, but neither the composition nor the intake of creep-feed by the piglets have been reported in this study. Nevertheless, the results of this study indicated that the beneficial effect of early-postnatal L-carnitine supplementation in low birth-weight piglets on myofibre number at weaning disappears during the post-weaning/growing and finishing period. Also, no effect of L-carnitine supplementation on BW gains and gain-to-feed ratio was observed in a very recent study with light-weight piglets (birth weight <1.2 kg, n = 36, female and entire male from Swiss Large White sows), which were early weaned on day 7 of age and artificially reared with a milk replacer based on cow milk products and offered either 0 (control) or 480 mg L-carnitine per day until day 28 of age (Madsen, Seoni, Kreuzer, Silacci, & Bee, 2018) . In addition, this study did not find any effects of supplemental L-carnitine on skeletal muscle weights and contractile and metabolic traits of skeletal muscle of early-weaned pigs (Madsen, Seoni et al., 2018) . However, it has to be considered that the basal L-carnitine content of the milk replacer used was probably relatively high, because it consisted mainly (97.4%) of cow milk products before (Madsen, Seoni et al., 2018) accounts for the lack of effect of supplemental L-carnitine.
Collectively, the available studies in low birth-weight piglets consistently show that supplemental L-carnitine provided either directly (orally) or via a milk replacer is ineffective in improving growth performance of suckling piglets and has no influence on the growth potential in the post-weaning period.
| Weaning and growing-finishing pigs
In contrast to the limited number of studies in suckling piglets, a great number of studies have been performed to investigate the effect of L-carnitine supplementation on performance of weaning pigs during the growing and/or finishing period. The outcomes of these studies with weaning pigs are significantly less consistent than those with suckling piglets (Table 5 ).
The first study reporting a beneficial effect of L-carnitine supplementation originates from Owen, Nelssen, Goodband, Weeden, and Blum (1996) showed that carcass fat content also was reduced in L-carnitinesupplemented pigs. These results indicated that supplemental Lcarnitine increases protein accretion, while reducing fat accretion in growing pigs. Also, Rincker et al. (2003) observed in a series of experiments with several hundreds of weaning pigs (different genotypes: Yorkshire × Hampshire, PIC C22, PIC L337 × C22) receiving graded levels of supplemental L-carnitine (0-100 mg/kg diet) during a 34-38-day-experimental period that 50 and 100 mg supplemental L-carnitine/kg diet increases average daily gain and gain-to-feed ratio during phase 2 (day 10-24 after weaning) and tends to increase average daily gain and improve gain-to-feed ratio for the entire 38-day post-weaning period. Notably, the corn-soya bean meal-based diets contained significant amounts of animal products (dried whey, spray-dried animal plasma, spray-dried blood meal and fish meal), which contain significant amounts of L-carnitine (Knüttel-Gustavsen & Harmeyer, 2007) , during the early growing phase (until day 24 of the experimental period). An interesting observation was made in the study of Birkenfeld et al. (2005) , in which the effect of supplemental L-carnitine (0 or 30 mg/kg diet) was investigated on growth performance of piglets (from German land race × Large white crossbred sows) after weaning (day 25 in experiment 1, day 30 in experiment 2). Experiment 1 included the piglets of the first litters (mean initial BW: 8.5 kg) of primiparous sows, while experiment 2 included piglets of the second litters (mean initial BW: 12.5 kg) of the same sows. In both experiments, piglets received a vegetarian diet low in L-carnitine consisting mainly of wheat, soya bean meal, barley, peas, rye, maize and wheat bran. Remarkably, L-carnitine supplementation increased BW gains and tended to increase gain-to-feed ratio only in piglets of the first trial, but had no effect in the second trial. This finding has been attributed to the fact that initial BWs of piglets in the first trial were markedly lower than in trial two and the ability of piglets to synthesize L-carnitine is particularly low in the first weeks of live (Borum, 1983) .
In contrast, most of the studies with weaning piglets observed no effects of supplemental L-carnitine. For instance, in an earlier study from Hoffman, Ivers, Ellersieck, and Veum (1993) The basal diet in this study was mainly corn-soya bean meal based but also contained 17% dried skim milk, which is a significant Lcarnitine source. In another study from Owen, Nelssen, Goodband, 
Note. BW, body weight.
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provided the optimum response on daily protein accretion and percentage of lean and muscle in growing-finishing pigs . Likewise, in a further study from Owen, Jit feeding of supplemental L-carnitine (0 or 500 mg/kg diet) in a typical corn (wheat and barley)-soya bean meal-based diet for 3 weeks failed to affect BW gain and gain-to-feed ratio of pigs compared to non-supplemented control pigs ). An effect of supplemental L-carnitine on carcass traits was not investigated in this study, but the authors showed that the supplemental Lcarnitine increased plasma and muscle total L-carnitine concentration by three-to fourfold and L-carnitine supplementation caused significant alterations of the muscle's transcriptome. This again indicated that supplemental L-carnitine affects skeletal muscle's metabolism of growing pigs.
In a study from James et al. (2013a) which consisted of a series of experiments with a total of n = 2,152 growing-finishing pigs (sex: gilts or barrows, genotype: progeny from C22 sows and 336 boars), the interactive effects of supplemental L-carnitine (0, 25 or 50 mg/kg diet) and ractopamine provided with a mainly corn-soya bean meal-based diet on growing-finishing pig performance was studied. With regard to the effect of supplemental L-carnitine, inconsistent effects between experiments were observed. In experiment 1 (n = 126 gilts, initial BW: 33 kg), supplemental L-carnitine had no effect on growth performance until a BW of 74 kg before ractopamine was fed. Also, in experiment 2 (n = 120 gilts, initial BW: 87 kg), supplemental L-carnitine alone did not improve growth performance until slaughter at 109 kg BW after 4 weeks.
In experiment 3 (n = 1,104 barrows, initial BW: 44 kg), supplemental L-carnitine did not improve growth performance in the pre-ractopamine period (experiment 3: from 44 to 92 kg BW), but improved average daily gain and gain-to-feed ratio in the 4-week ractopamine period (from 92 kg until slaughter at 118 kg BW). In experiment 4 with n = 796 barrows (initial BW: 103 kg), supplemental L-carnitine increased average daily gain and gain-to-feed ratio during the 3 weeks until slaughter at 118 kg BW. This study indicated that supplemental L-carnitine at a dose of 50 mg/kg diet is beneficial for growth performance when fed during the finishing period (>90 kg BW), but not during the growing period. In an accompanying paper from James et al. (2013b) , it was reported that supplemental L-carnitine decreased fat thickness and lean percentage in pigs of experiment 3. 
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